Involvement of spinal serotonin receptors in the regulation of intraspinal acetylcholine release

Abstract

Stimulation of spinal serotonin (5-HT) receptors results in analgesia and release of acetylcholine. We investigated the involvement of 5-HT 1, 5-HT 2, and 5-HT 3 receptor subtypes in the regulation of spinal acetylcholine release. A spinal microdialysis probe was placed dorsally at about the C5 level in anaesthetized rats. The selective serotonin reuptake inhibitor citalopram was found to increase acetylcholine release when infused via the microdialysis probe. Several doses of the 5-HT receptor agonists 8-hydroxy-2-(di- n-propylamino)tetraline (8-OH-DPAT, 5-HT 1A), 1,4-dihydro-3-(1,2,3,6-tetrahydro-4-pyridinyl)-5H-pyrrolo[3,2- b]pyridin-5-one dihydrochloride (CP93129, 5-HT 1B), α-methyl-5-hydroxytryptamine maleate (m5-HT, 5-HT 2), 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI, 5-HT 2C), and 1-( m-chlorophenyl)-biguanide (5-HT 3) were subsequently infused via the microdialysis probe. Only 8-OH-DPAT, CP93129, and m5-HT increased acetylcholine release dose dependently. The 5-HT 1A receptor selective antagonist ( S)- N- tert-butyl-3-(4-(2-methoxyphenyl)piperazine-1-yl)-2-phenylpropanamide hydrochloride and the 5-HT 2A receptor selective antagonist ketanserin tartrate inhibited the 8-OH-DPAT and the m5-HT induced acetylcholine release. The results suggest that 5-HT 1A and the 5-HT 2A receptors are involved in the regulation of acetylcholine release in the spinal cord.